Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBT (2016 - 2026)

Cryo Cell International's EBT history spans 17 years, with the latest figure at $70309.0 for Q1 2026.

  • Quarterly results put EBT at $70309.0 for Q1 2026, down 86.83% from a year ago — trailing twelve months through Feb 2026 was -$2.8 million (down 210.11% YoY), and the annual figure for FY2025 was -$2.3 million, down 183.35%.
  • EBT for Q1 2026 was $70309.0 at Cryo Cell International, up from -$4.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.5 million in Q2 2024 to a low of -$16.0 million in Q4 2023.
  • The 5-year median for EBT is $640966.0 (2022), against an average of -$559310.0.
  • The sharpest move saw EBT plummeted 2669.13% in 2023, then skyrocketed 324.98% in 2024.
  • Year by year, EBT stood at $622508.0 in 2022, then plummeted by 2669.13% to -$16.0 million in 2023, then soared by 94.73% to -$842434.0 in 2024, then crashed by 449.83% to -$4.6 million in 2025, then soared by 101.52% to $70309.0 in 2026.
  • According to Business Quant data, EBT over the past three periods came in at $70309.0, -$4.6 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.